摘要
目的:观察连草泻痢胶囊对急性溃疡性结肠炎(UC)患者外周血巨噬细胞表型的影响。方法:选取82例符合纳入标准的UC患者,随机分成对照组和观察组,每组41例。其中对照组给予美沙拉嗪肠溶片口服治疗,观察组在此基础上予连草泻痢胶囊口服治疗,疗程8周;分别检测两组患者治疗前后外周血巨噬细胞百分比和血清炎症因子(IL-6、IL-1β、IL-4、IL-10)水平。结果:对照组和观察组治疗后IL-6、IL-1β和M1型巨噬细胞百分比均显著下降(P<0.05),IL-4、IL-10和M2型巨噬细胞百分比均显著上升(P<0.05)。连草泻痢胶囊治疗观察组上述变化较单纯美沙拉嗪治疗对照组显著。结论:连草泻痢胶囊可通过巨噬细胞极化促进外周血巨噬细胞向M2表型极化,抑制M1表型,进而有效控制UC炎症。
Objective:To observe the effects of Liancao Xieli Capsule on the phenotype of peripheral blood macrophages in patients with acute ulcerative colitis(UC).Methods:82 patients with UC were randomly divi-ded into control group and observation group,41 cases in each group.The control group was treated with Mesalazine enteric-coated tablets orally,and the observation group was treated with Liancao Xieli Capsule orally on this basis for 8 weeks.The percentage of peripheral blood macrophages and the levels of serum inflammatory factors(IL-6,IL-1β,IL-4,IL-10)were observed and detected before and after treatment in the two groups.Results:After treatment,the percentages of M1 macrophages and IL-6,IL-1βlevels in the control group and the observation group were significantly decreased(P<0.05),and the percentages of M2 macrophages and IL-4,IL-10 levels were significantly increased(P<0.05).The above changes in the observation group treated with Liancao Xieli Capsule were more significant than those in the control group treated with Mesalazine alone.Conclusion:Liancao Xieli Capsule can promote the polarization of peripheral blood macrophages to M2 phenotype and inhibit M1 phenotype through macrophage polarization,thus effectively controlling UC inflammation.
作者
张雅丽
喻学婷
袁星星
张传举
高婷婷
高佳炜
杨柳欣
ZHANG Yali;YU Xueting;YUAN Xingxing;ZHANG Chuanju;GAOTingting;GAO Jiawei;YANG Liuxin(Heilongjiang Academy of Chinese Medicine Sciences,Harbin,Heilongjiang 150036;Zhang Yali Senior Traditional Chinese Medicine Expert Studio,Harbin,Heilongjiang 150006;Heilongiiang University of Chinese Medicine,Harbin,Heilongjiang 150040)
出处
《中国中医药科技》
CAS
2023年第6期1043-1046,共4页
Chinese Journal of Traditional Medical Science and Technology
基金
黑龙江省自然科学基金项目(LH2019H095)。